D.E. Shaw & Co’s Signify Health, Inc. SGFY Stock Holding History

D.E. Shaw & Co’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-26,529	Closed	-$760K	–	5090
2022 Q4	$760K	Sell	26,529 -18,802	-41%	-$543K	﹤0.01%	3628
2022 Q3	$1.32M	Buy	45,331 +12,424	+38%	+$286K	﹤0.01%	3368
2022 Q2	$454K	Sell	32,907 -127,688	-80%	-$1.8M	﹤0.01%	4145
2022 Q1	$2.92M	Buy	160,595 +102,150	+175%	+$1.46M	﹤0.01%	2929
2021 Q4	$831K	Sell	58,445 -49,298	-46%	-$763K	﹤0.01%	4084
2021 Q3	$1.93M	Buy	+107,743	New	+$2.77M	﹤0.01%	3067

Other funds holding SGFY

BHCM

Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

D.E. Shaw & Co's SGFY Position: Q1 2023 in Review

D.E. Shaw & Co sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 26,529 shares — an estimated $760K sold.

D.E. Shaw & Co first reported a position in SGFY in Q3 2021 and held it in 6 quarters. The position peaked at $2.92M in Q1 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

D.E. Shaw & Co reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
D.E. Shaw & Co sold 26,529 Signify Health, Inc. shares in Q1 2023, an estimated $760K.
D.E. Shaw & Co first reported a position in Signify Health, Inc. in Q3 2021 and held it in 6 quarters.
D.E. Shaw & Co's Signify Health, Inc. position peaked at $2.92M in Q1 2022.
5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.